Search

Author/Creator Conget, Ignacio

2. Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain. Issue 7 (26th July 2016)

Authors:
Conget, Ignacio; Mauricio, Dídac; Ortega, Rafael; Detournay, Bruno
Other Names:
author non-byline.; Muros Teresa author non-byline.; de la Cuesta Carmen author non-byline.; Mangas Miguel Ángel author non-byline.; Herrero Cristina Hernández author non-byline.; de Castro Hernandez Paloma author non-byline.; Peralta Fernando Gómez author non-byline.; García Manuel Miralles aut...
Journal:
BMJ open
Issue:
Volume 6:Issue 7(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Issue 1 (14th July 2017)

Authors:
Gerstein, Hertzel C.; Colhoun, Helen M.; Dagenais, Gilles R.; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Riddle, Matthew C.; Rydén, Lars; Xavier, Denis; Atisso, Charles M.; Avezum, Alvaro; Basile, Jan; Chung, Namsik; Conget, Ignacio; Cushman, William C.; Franek, Edward; Han...
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 1(2018)
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Detailed description of a prepregnancy care program and its impact on maternal glucose control, weight gain, and dropouts†. Issue 2 (18th August 2016)

Authors:
Perea, Verónica; Orois, Aida; Amor, Antonio J.; Jansà, Marga; Vidal, Merce; Gimenez, Marga; Conget, Ignacio; Vinagre, Irene
Journal:
Diabetes/metabolism research and reviews
Issue:
Volume 33:Issue 2(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial. (20th September 2022)

Authors:
Branch, Kelley R.H.; Dagenais, Gilles R.; Avezum, Alvaro; Basile, Jan; Conget, Ignacio; Cushman, William C.; Jansky, Petr; Lakshmanan, Mark; Lanas, Fernando; Leiter, Lawrence A.; Pais, Prem; Pogosova, Nana; Raubenheimer, Peter J.; Ryden, Lars; Shaw, Jonathan E.; Sheu, Wayne H.H.; Temelkova‐Kurkts...
Journal:
European journal of heart failure
Issue:
Volume 24:Number 10(2022)
Page Start:
1805
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019)

Authors:
Gerstein, Hertzel C; Colhoun, Helen M; Dagenais, Gilles R; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Riesmeyer, Jeffrey S; Riddle, Matthew C; Rydén, Lars; Xavier, Denis; Atisso, Charles Messan; Dyal, Leanne; Hall, Stephanie; Rao-Melacini, Purnima; Wong, Gloria; Avezum, Alv...
Journal:
Lancet
Issue:
Volume 394:Issue 10193(2019)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019)

Authors:
Gerstein, Hertzel C; Colhoun, Helen M; Dagenais, Gilles R; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Riesmeyer, Jeffrey S; Riddle, Matthew C; Rydén, Lars; Xavier, Denis; Atisso, Charles Messan; Dyal, Leanne; Hall, Stephanie; Rao-Melacini, Purnima; Wong, Gloria; Avezum, Alv...
Journal:
Lancet
Issue:
Volume 394:Issue 10193(2019)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Issue 4 (24th January 2022)

Authors:
Raubenheimer, Peter J.; Cushman, William C.; Avezum, Alvaro; Basile, Jan; Conget, Ignacio; Dagenais, Gilles; Hoover, Anastasia; Jansky, Petr; Lanas, Fernando; Leiter, Lawrence A.; Lopez‐Jaramillo, Patricio; Pogosova, Nana; Probstfield, Jeffrey; Rao‐Melacini, Purnima; Rydén, Lars; Sheu, Wayne H.‐H...
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 24:Issue 4(2022)
Page Start:
704
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Issue 10193 (13th July 2019)

Authors:
Gerstein, Hertzel C; Colhoun, Helen M; Dagenais, Gilles R; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Botros, Fady T; Riddle, Matthew C; Rydén, Lars; Xavier, Denis; Atisso, Charles Messan; Dyal, Leanne; Hall, Stephanie; Rao-Melacini, Purnima; Wong, Gloria; Avezum, Alvaro; B...
Journal:
Lancet
Issue:
Volume 394:Issue 10193(2019)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial. Issue 8 (August 2021)

Authors:
Bajaj, Harpreet S; Gerstein, Hertzel C; Rao-Melacini, Purnima; Basile, Jan; Colhoun, Helen; Conget, Ignacio; Cushman, William C; Dagenais, Gilles R; Franek, Edward; Hanefeld, Markolf; Keltai, Matyas; Lakshmanan, Mark; Lanas, Fernando; Leiter, Lawrence A; Lopez-Jaramillo, Patricio; Pirags, Valdis;...
Journal:
Lancet
Issue:
Volume 9:Issue 8(2021)
Page Start:
484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗